IART
Integra Lifesciences Holdings·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
IART fundamentals
Integra Lifesciences Holdings (IART) released its earnings on Oct 30, 2025: revenue was 402.06M (YoY +5.57%), missed estimates; EPS was 0.54 (YoY +31.71%), beat estimates.
Revenue / YoY
402.06M
+5.57%
EPS / YoY
0.54
+31.71%
Report date
Oct 30, 2025
IART Earnings Call Summary for Q3,2025
- Revenue Growth Despite Challenges: Q3 2025 organic revenue up 5%, driven by Neurosurgery and Wound Reconstruction, but offset by CSS supply disruptions.
- Strategic Progress: Relaunched PriMatrix/Durepair ahead of schedule via dual sourcing; Integra Skin yields improved 50%.
- Cost Savings Initiative: $25-30M 2026 savings from COGS and operating model efficiencies.
- Financial Resilience: Adjusted EPS beat ($0.54 vs. $0.41 prior year), despite 260bps gross margin headwinds.
- Key Risks: Private label partner softness, tariff impacts, and Compliance Master Plan costs weighing on margins.
EPS
Revenue
Revenue & Expenses
IART has released its 2025 Q3 earnings report, with revenue of 402.06M, reflecting a YoY change of 5.57%, and net profit of -5.40M, showing a YoY change of 49.47%. The Sankey diagram below clearly presents IART's revenue sources and cost distribution.
Key Indicators
Integra Lifesciences Holdings (IART) key financial stats and ratios, covering profitability, financial health, and leverage.
Integra Lifesciences Holdings (IART)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Integra Lifesciences Holdings (IART)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Integra Lifesciences Holdings (IART)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Integra Lifesciences Holdings (IART) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Integra Lifesciences Holdings (IART) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What does Integra Lifesciences Holdings do and what are its main business segments?Did Integra Lifesciences Holdings beat or miss consensus estimates last quarter?What factors drove the changes in Integra Lifesciences Holdings's revenue and profit?What were the key takeaways from Integra Lifesciences Holdings's earnings call?What is the revenue and EPS growth rate for Integra Lifesciences Holdings year over year?What is the market's earnings forecast for Integra Lifesciences Holdings next quarter?What guidance did Integra Lifesciences Holdings's management provide for the next earnings period?What were the key takeaways from Integra Lifesciences Holdings’s earnings call?
